email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
1126 - 1140
of 3612 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Everest Medicines In-licenses BTK for Renal Diseases in $561 Million Deal
$5.00
Available
IASO Completes $108 Million C Round for Novel Cell Therapies
$5.00
Available
Cytovia Raises $45 Million for JV to Develop NK Products in China
$5.00
Available
Haisco Enters $140 Million Deal for Osteoarthritis Therapy
$5.00
Available
CStone to Start China Trials of Tri-Specific Immunotherapy in Solid Tumor Cancers
$5.00
Available
Alebund Pharma Raises $54.5 Million for Renal Disease Therapies
$5.00
Available
Harbour Bio to Start China Trials of CLTA-4/PD-1 Combo in Two Additional Cancers
$5.00
Available
Legend Bio Starts US Trial of CD4 CAR-T Therapy for Lymphoma
$5.00
Available
Huadong and Insilico Partner to Discover Novel Oncology Candidates
$5.00
Available
Frontage Acquires Majority Stake in Wuhan Heyan Biomedical, a CRO
$5.00
Available
Sanofi Acquires Kadmo, its Novel GVHD Therapy and China JV
$5.00
Available
Bio-Thera Out-Licenses Ex-China Rights for Avastin Biosimilar to Sandoz
$5.00
Available
Brii Bio Allocates $100 Million to Bring Dual SARS-CoV-2 mAb Therapy to Market
$5.00
Available
JW Therapeutics to Launch CD-19 CAR-T in China for Lymphoma
$5.00
Available
Arctic Vision Will Start Phase III Trial of Nearsightedness Therapy in China
$5.00
Available